Abstract Analysis of 501 melanoma exomes identified RASA2, encoding a RasGAP, as a
tumor-suppressor gene mutated in 5% of melanomas. Recurrent loss-of-function mutations in …

Abstract Analysis of 501 melanoma exomes revealed RGS7, which encodes a GTPase-accelerating
protein (GAP), to be a tumor-suppressor gene. RGS7 was mutated in 11% of …

Recent technological advances in sequencing have flooded the field of cancer research with
knowledge about somatic mutations for many different cancer types. Most cancer genomics …

The antigenicity of cells is demarcated by the peptides bound by their Human Leucocyte
Antigen (HLA) molecules. Through this antigen presentation, T cell specificity response is …

Oncogene-induced senescence, eg, in melanocytic nevi, terminates the expansion of pre-malignant
cells via transcriptional silencing of proliferation-related genes due to decoration of …

Coronavirus disease 2019 (COVID-19) is a highly contagious illness that spreads rapidly
through human-to-human transmission. On March 5, the government of Palestine declared a …

The quest for tumor-associated antigens (TAA) and neoantigens is a major focus of cancer
immunotherapy. Here, we combine a neoantigen prediction pipeline and human leukocyte …

The incidence of melanoma continues to rise globally and is increasing at a rate greater than
any other cancer. To systematically search for new genes involved in melanomagenesis, …

Objective: To assess whether Parkinson disease (PD) genes are somatically mutated in
cutaneous melanoma (CM) tissue, because CM occurs in patients with PD at higher rates than …

The ionotropic glutamate receptors (N-methyl-D-aspartate receptors (NMDARs)) are composed
of large complexes of multi-protein subunits creating ion channels in the cell plasma …